Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Technical University of Munich (TUM), 85748 Garching, Germany.
Cells. 2021 Jun 25;10(7):1598. doi: 10.3390/cells10071598.
Hutchinson-Gilford progeria syndrome (HGPS) is a segmental premature aging disease caused by a mutation in . The mutation generates a truncated and farnesylated form of prelamin A, called progerin. Affected individuals develop several features of normal aging, including lipodystrophy caused by the loss of general subcutaneous fat. To determine whether premature cellular senescence is responsible for the altered adipogenesis in patients with HGPS, we evaluated the differentiation of HGPS skin-derived precursor stem cells (SKPs) into adipocytes. The SKPs were isolated from primary human HGPS and normal fibroblast cultures, with senescence of 5 and 30%. We observed that the presence of high numbers of senescent cells reduced SKPs' adipogenic differentiation potential. Treatment with baricitinib, a JAK-STAT inhibitor, ameliorated the ability of HGPS SKPs to differentiate into adipocytes. Our findings suggest that the development of lipodystrophy in patients with HGPS may be associated with an increased rate of cellular senescence and chronic inflammation.
亨廷顿舞蹈病-早老综合征(HGPS)是一种节段性过早衰老疾病,由 基因突变引起。该突变会产生截短的并法呢基化的前层粘连蛋白 A,称为早衰素。受影响的个体表现出几种正常衰老的特征,包括由于一般皮下脂肪丧失引起的脂肪营养不良。为了确定过早的细胞衰老是否是 HGPS 患者脂肪生成改变的原因,我们评估了 HGPS 皮肤衍生前体干细胞(SKP)向脂肪细胞的分化。SKP 从原发性人 HGPS 和正常成纤维细胞培养物中分离出来,衰老程度为 5%和 30%。我们观察到大量衰老细胞的存在降低了 SKP 的脂肪生成分化潜力。用 JAK-STAT 抑制剂巴瑞替尼治疗可改善 HGPS SKP 向脂肪细胞分化的能力。我们的研究结果表明,HGPS 患者脂肪营养不良的发展可能与细胞衰老和慢性炎症的发生率增加有关。